The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites
| العنوان: | The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites |
|---|---|
| المؤلفون: | Oliver Looker, Madeline G. Dans, Hayley E. Bullen, Brad E. Sleebs, Brendan S. Crabb, Paul R. Gilson |
| المصدر: | Traffic. 23:442-461 |
| بيانات النشر: | Wiley, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Erythrocytes, Plasmodium falciparum, Protozoan Proteins, Cell Biology, Biochemistry, Malaria, Antimalarials, Structural Biology, Genetics, Animals, Humans, Parasites, Malaria, Falciparum, Molecular Biology |
| الوصف: | Plasmodium falciparum parasites which cause malaria, traffic hundreds of proteins into the red blood cells (RBCs) they infect. These exported proteins remodel their RBCs enabling host immune evasion through processes such as cytoadherence that greatly assist parasite survival. As resistance to all current anti-malarial compounds is rising new compounds need to be identified and those that could inhibit parasite protein secretion and export would both rapidly reduce parasite virulence and ultimately lead to parasite death. To identify compounds that inhibit protein export we used transgenic parasites expressing an exported nanoluciferase reporter to screen the Medicines for Malaria Venture Malaria box of 400 anti-malarial compounds with mostly unknown targets. The most potent inhibitor identified in this screen was MMV396797 whose application led to export inhibition of both the reporter and endogenous exported proteins. MMV396797 mediated blockage of protein export and slowed the rigidification and cytoadherence of infected RBCs - modifications which are both mediated by parasite-derived exported proteins. Overall, we have identified a new protein export inhibitor in P. falciparum whose target though unknown, could be developed into a future anti-malarial that rapidly inhibits parasite virulence before eliminating parasites from the host.SynopsisPlasmodium falciparum exports proteins into its host cell to perform a myriad of functions required for survival. We adapted an assay to screen for small molecules that inhibit protein secretion and export. Screening the 400-compound Medicines for Malaria Venture (MMV) Malaria Box uncovered several potential export inhibitors. The most promising of these compounds, MMV396797, blocked protein export at the parasite and reduced host rigidification and cytoadherence, two functions which are mediated by exported proteins. |
| تدمد: | 1600-0854 1398-9219 |
| DOI: | 10.1111/tra.12862 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f981b5ac5b72d73b0195d0fe45a4081e https://doi.org/10.1111/tra.12862 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....f981b5ac5b72d73b0195d0fe45a4081e |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 16000854 13989219 |
|---|---|
| DOI: | 10.1111/tra.12862 |